It has been reported that blockade of CXCR1 and CXCR2 using SCH 527123 antagonist potentially inhibits human colon cancer liver metastasis (16) and also sensitizes cells to oxaliplatin (17). Here, CXCR2 is linked to colonic neoplasm.